A fission yeast-based platform for phosphodiesterase inhibitor HTSs and analyses of phosphodiesterase activity

13Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Fission yeast strains have been engineered so that their growth behavior reflects the activity of heterologous cyclic nucleotide phosphodiesterases (PDEs). These strains can be used in High-Throughput Screens (HTSs) for PDE inhibitors that possess "drug-like" characteristics, displaying activity in a growth stimulation assay over a 48-h period. Through three generations of development, a collection of strains expressing 10 of the 11 mammalian PDE families that is appropriate for small molecule inhibitor screening has been generated in our laboratory. Strains unable to synthesize cyclic nucleotides allow characterization of PDE activity in that the enzyme's potency is reflected in the amount of either cAMP or cGMP that must be added to the growth medium to stimulate cell growth. In the future, this system could be used to screen cDNA libraries for biological regulators of target PDEs and for the construction of strains that co-express PDEs and associated regulatory proteins to facilitate molecular and genetic studies of their functions and, in particular, to identify whether different PDE-partner protein complexes show distinct patterns of inhibitor sensitivity. © 2011 Springer-Verlag Berlin Heidelberg.

Cite

CITATION STYLE

APA

Demirbas, D., Ceyhan, O., Wyman, A. R., & Hoffman, C. S. (2011). A fission yeast-based platform for phosphodiesterase inhibitor HTSs and analyses of phosphodiesterase activity. Handbook of Experimental Pharmacology, 204, 135–149. https://doi.org/10.1007/978-3-642-17969-3_5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free